
In an interview with CURE, Dr. Lakshmi Nayak explains how an FDA label update expands Yescarta access for relapsed or refractory primary CNS lymphoma.

In an interview with CURE, Dr. Lakshmi Nayak explains how an FDA label update expands Yescarta access for relapsed or refractory primary CNS lymphoma.

Cancer-related fatigue may persist despite improved sleep or treated depression, underscoring it as a distinct and complex symptom.

Dr. William Audeh discusses how genomic subtyping can close the 38% mortality gap for Black women by identifying aggressive basal-type cancers.

Dr. Rodney Haring discusses strategies to reduce cancer mortality among Native Americans through patient navigation, clinical trials and tribal sovereignty.

Dr. Alex Francoeur of UC Irvine urges patients with ovarian cancer to ask questions, seek second opinions and build trusted relationships with oncologists.

A study led by Dr. J. William Harbour of UT Southwestern Medical Center marks a shift in how doctors predict the spread of uveal melanoma.

Heather Quintana Suchan shares how work and music community support her while she lives fully with stage 4 lung cancer.

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get diagnosed earlier and live longer.

This device detects and characterizes lesions on low-dose CT scans, helping patients with cancer get faster, tailored care and avoid unnecessary procedures.

Study finds similar PFS across races in ovarian cancer trials, but Black patients had shorter OS, raising concerns about disparities after trial completion.

Dr. Ashkan Emadi outlines eligibility, referral and care logistics for a first-in-world subcutaneous Blincyto trial at WVU Cancer Institute.

A three-time survivor shares why persistent symptoms, second opinions and mental health support matter after cervical cancer.

Six-time cancer survivor encourages patients to trust doctors, lean on support, and save energy for moving forward instead of fear.

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment.

A liver cancer survivor shares transplant insights, dispels living donor myths and urges patients to advocate for informed, hopeful care.

A three-time cervical cancer survivor urges patients with cancer to be thorough, seek multiple opinions and trust their gut to find providers who listen, validate concerns and truly support them.

Dr. Sue Hwang, a radiation oncologist and breast cancer survivor, sheds light on the reality of cancer survivorship.

CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing.

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

Former NFL player and advocate Chris Draft urges patients with cancer to recognize small actions, learn terms and stay engaged to rebuild confidence after diagnosis.

Colleen Mabasa shared her experience navigating CAR-T cell therapy beyond the clinical aspects of treatment.

In a recent CURE conversation, Charles Walker shared how months of unexplained fatigue and back pain ultimately led to a life-altering diagnosis.

CURE spoke with Dr. Kathie-Ann Joseph about the importance of personalized, multidisciplinary treatments when caring for patients with breast cancer.

Dr. Sue Hwang explains how she went from a care provider who helped others through their cancer journeys to a patient facing a cancer diagnosis of her own.

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their cancer.

Dr. Elias Obeid says ongoing monitoring after treatment helps detect recurrence early and identify late effects, supporting survivorship for patients.

Dr. Suneel Kamath emphasized the growing importance of understanding biomarkers in patients with gastrointestinal cancers.

Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.

Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and manage gastrointestinal symptoms during treatment.